Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that increasingly is being studied in different aspects of cancer and inflammatory diseases.
Introduction
Clinically relevant animal models help in understanding the pathogenesis of different human and animal diseases and also play crucial roles in developing new therapeutics against them. In spite of the dominance of mouse as an experimental model animal, hamster has carved its niche as a potential model animal for studying many diseases and for evaluation of therapeutic agents. Syrian golden hamsters (Mesocricetus auratus) are frequently used in various disease pathogenesis studies due to the ease of handling them and the similarity to humans in disease development. Hamsters are important animal models for studying various infectious diseases of humans [1] [2] [3] [4] [5] [6] [7] [8] . The hamster models of pancreatic and oral cancer have gained importance in their respective fields [9] [10] [11] [12] [13] [14] . Moreover, these animals have also been instrumental in studying metabolic and/or inflammatory diseases like diabetes and pancreatitis [15, 16] . Despite the fact that Syrian golden hamster is an important clinically relevant animal model for different diseases, it is not used to its full potential. In this aspect, non-availability of complete genetic information of these animals and a lack of biological reagents related to them are the major constrains.
Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine with pleotropic functions in various pathophysiological processes [17] [18] [19] [20] . Though initially identified as a T cell-derived cytokine that inhibits macrophage migration, its pleiotropic effects on immune cells, cancer cells, as well as non-cancerous cells made MIF more enigmatic to the researchers. Involvement of MIF in a number of human diseases like pulmonary hypertension, endothelial cell growth, atherosclerosis, wound healing, viral infection, many cancers including lung, colon, prostate, breast and pancreatic cancer has bagged a significant interest in this molecule [21] . In one of our earlier published study, we have characterized HapT-1 cell line-based Syrian hamster tumor as a model of pancreatic cancer associated desmoplasia, an event which plays a key role in human pancreatic cancer progression [10] . In that study, for the first time, global proteomics analysis of whole cell lysate from hamster pancreatic stellate cells (PSCs) showed expression of macrophage migration inhibitory factor (MIF) by the cells [10] . At that particular time, due to unavailability of information and reagents for hamster MIF, we were unable to investigate the function of this molecule in the hamster model of pancreatic cancer. Hence, in the current study, our major objective was to characterize the hamster MIF protein, and evaluate the effect of exogenous MIF on the growth of pancreatic tumor in a syngeneic model of hamster pancreatic cancer.
In the current study, we have successfully purified recombinant hamster MIF protein (rha-MIF) from a bacterial protein expression system. Our analysis showed that like human MIF, rha-MIF also forms a trimer in solution. A commercially available MIF anybody raised against human MIF cross-reacts with rha-MIF. We resolved the trimeric rha-MIF crystal structure at 1.8 Å resolution, and the structural analysis showed multiple features in rha-MIF to be similar to mouse and human MIF. Further, biochemical and cell culture based studies using endotoxin free rha-MIF showed it's enzymatic (tautomerase) and immunostimulatory activities, which suggests that the purified protein is biologically active. Importantly, all the biological properties of rha-MIF investigated in this study were similar to human MIF. At the end, we have investigated the effect of rha-MIF on the growth of HapT-1 pancreatic tumor in its syngeneic host. The data clearly shows the pro-tumorigenic effect of rha-MIF on the HapT-1 pancreatic tumor. Taken together, the data presented in this study has unraveled multiple information regarding hamster MIF, and indicates the importance of hamster as a model to investigate questions related to the role of MIF in pancreatic cancer progression.
Materials and methods

Recombinant hamster MIF (rha-MIF) expression, purification and Western blotting
Syrian golden hamster (Mesocricetus auratus) MIF open reading frame sequence (spanning residues 1-115) was PCR amplified and cloned in between NdeI and XhoI sites of a pET22b+ vector with an uncleavable C-terminal hexa-histidine tag. The protein was expressed in E. coli BL21 (DE3) cells at an OD600nm of 0.6, by induction with 0.5 mM IPTG for 4 hours at 37 o C. Cells from 1 liter culture were pelleted down by centrifugation for 10 min at 7,000 r.p.m. and then suspended in 50 ml of buffer A buffer containing 20 mM Tris-HCl (pH 7.5), 20 mM imidazole, 300 mM NaCl, 1 mM βME, 1 mM PMSF and one tablet of EDTA-free protease inhibitor cocktail (Sigma).
The cells were lysed by sonication and the lysate clarified by centrifugation at 18,000 r.p.m. for 45 minutes. Recombinant hamster MIF (rha-MIF) was first captured on a Ni-NTA affinity column (HisTrap FF 5 ml, GE Healthcare). Then the column was washed with 15 column volumes of buffer A and eluted with a linear gradient of buffer B (buffer A supplemented with 500 mM imidazole), followed by size-exclusion chromatography using a HiLoad 16/600 Superdex 75 pg column (GE Healthcare) with buffer C containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1 mM DTT. The peak fractions containing MIF were pooled and concentrated to 30 mg/ml and stored at -80 o C. The purified protein was analyzed on 18% SDS-PAGE and stained with Coomassie Brilliant Blue to confirm the purity and to get an estimate of the monomeric molecular mass. To estimate the approximate molecular mass of purified hamster MIF in native conformation, i.e. to find whether the protein exists in an oligomeric form, analytical size-exclusion chromatography was performed using buffer C on a Superdex 200 10/300 GL column. Low molecular weight standards were used as a reference for molecular mass measurement. For biochemical experiments, endotoxin was removed from purified rha-MIF using Vivaspin endotest tubes (Sartorius Biotech, Germany).
Next, the E. coli-derived recombinant hamster MIF used in our biochemical experiments was used to perform Western blot to elucidate the cross-reactivity of MIF polyclonal antibody (NBP1-81832; Novus Biologicals) towards hamster MIF, since this antibody was raised against a recombinant protein with 100% identity with human MIF and 89% identity with Syrian hamster MIF.
CD spectroscopy
CD spectra of 10 μM rha-MIF in a buffer containing 10 mM sodium phosphate (pH 7.4) and 50 mM NaCl was recorded using a Chirascan CD spectroscope (Applied Photophysics). The spectra were collected in triplicate from 190 nm to 260 nm at 25°C at a bandwidth of 1.0 nm using a quartz cuvette with 10 mm path length. All the spectra were averaged and the buffer spectra subtracted from those of sample. The estimation of secondary structural elements was done using the BeStSel server [22] . The CD intensities (in millidegree) are plotted against wavelength.
Multiple sequence alignment and phylogenetic tree analysis
Protein sequences of Syrian golden hamster MIF (UniProtKB: A0A140EDM8), mouse MIF (UniProtKB: P34884) and human MIF (UniProtKB: P14174) were aligned using PRALINE multiple sequence alignment program and residue substitution matrix BLOSUM62 at http://www.ibi.vu.nl/programs/pralinewww/. PRALINE sequence conservation score 0 was given for the least conserved position and 10 for the most conserved position of alignment. Phylogenetic tree was constructed with MEGA 7 software [23] using the Neighbor-Joining method. [24] . The optimal tree with the sum of branch length is 0.15113287 and was drawn to scale with branch lengths (below the branches) in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson method in the units of a number of residue substitutions per position.
Crystallization and data collection
Recombinant hamster MIF (15 mg/ml) was screened for crystallization at 18 o C using commercially available screens with the help of an NT8 crystallization robot (Formulatrix, USA) in 96-well sitting drop crystallization plates. After 3 days, small and two-dimensional crystals appeared in a few conditions. The sequential microseeding approach was adopted for further optimization. Towards this end, crystals grown in a condition with 50% v/v PEG 400, 200 mM lithium sulfate and 100 mM sodium acetate (pH 7.5) were crushed and used for micro-seeding into the same condition, but in bigger drops with 1 l protein and 1 l condition, using hanging drop vapour diffusion method. After a week, bigger crystals appeared but were still twodimensional in morphology. These crystals were picked, crushed and used as seed material for fresh crystallization screens following the random micro-seed matrixscreening method [25] 
Data processing, structure determination and refinement
The diffraction images were processed using XDS [26] . The crystal structure of hamster MIF was solved by molecular replacement method using the program Molrep [27] from the CCP4 suite [28] , using the mouse MIF crystal structure (PDB id: 1mff) as the search model. Crystallographic refinement and model building were performed iteratively using Refmac5 [29] and Coot [30] . The quality of the final model was assessed using the Ramachandran Plot from the program PROCHECK [31] . All the figures were prepared using PyMOL (Schrödinger, LLC). The data collection and refinement statistics are provided in table 1. The structure factors and refined coordinates have been deposited in the PDB, with the accession code 6ice.
Tautomerase assay
MIF from other species has been reported to possess one unusual activity of catalyzing the tautomerization of D-dopachrome and L-dopachrome methyl ester into their corresponding indole derivatives. Tautomerase assay was carried out as described previously [32] . To analyze the tautomerase activity of rha-MIF, 4 mM of L-3,4-dihydroxyphenylalanine methyl ester was diluted in 5 ml autoclaved water and an appropriate amount of sodium periodate was added to it to make a final concentration of 8 mM. The mixture was incubated on ice for 20 minutes in the dark. 300 l from this solution was mixed with 700 l of the assay buffer consisting of 50 mM potassium phosphate and 1 mM EDTA (pH 6.0). Different concentrations of MIF were added to it and the decrease in absorbance at 475 nM was recorded after different time points of incubation.
Effect of MIF on the expression of inflammation-associated genes in hamster peripheral blood mononuclear cells (ha-PBMCs)
To check the effect of MIF on the expression status of certain inflammation-associated genes in ha-PBMCs, cells were isolated from hamster blood using the Histopaque gradient as suggested by the manufacturer (Sigma, USA). The isolated ha-PBMCs were cultured in 10 % RPMI media and treated with rha-MIF (100 ng/ml), ISO-1 (100 M) or rha-MIF+ISO-1 for 4 hours. Then cells were harvested in RLT buffer and processed for RNA isolation as described by the manufacturer (Qiagen, USA). RNA quantification was carried out using Nanodrop followed by cDNA synthesis [10] . The expression levels of Il-1, Tnf-, Vegf, and Il-6 were analyzed in all the cDNA samples through qPCR, by using gene-specific primers.
Effect of MIF on PBMC migration
Prior to conducting any animal studies, all protocols were approved by the Institutional Animal Ethical Committee (Institute of Life Sciences, Bhubaneswar, India).
Preparation of hamster peripheral blood mononuclear cells was carried out as previously described [33] . Briefly, normal hamsters having no symptomatic diseases were euthanized and blood was collected through the cardiac puncture in heparinized tube followed by histopaque (Sigma, 11191) gradient centrifugation. After gradient centrifugation, the cells present in buffy coat layer were aspirated and washed twice with 10 ml PBS followed by resuspension in 2 to 3 ml of 0% FBS containing RPMI media. Cell counting was done through the trypan blue dye exclusion method. To check the effect of recombinant hamster MIF on the migration of hamster PBMCs, 3.5x10 5 PBMCs in 0% FBS containing media (500 µl) were seeded in 8 µm pore trans-well insert (Millicell Hanging Cell Culture Insert, PET 8 µm, 12-well, MCEP12H48) and lower chamber was added either with 1% FBS containing media, 10% FBS containing media or 100 ng recombinant hamster MIF in 1% FBS containing media as chemoattractant (600 µl). Each experimental condition was carried out in triplicate.
After 2 hours of incubation at 37 o C and 5% CO2, the cells were fixed in 10% buffered formalin for 10 minutes followed by staining with 0.1% crystal violet. Cells adhered to the upper surface of the membrane were removed with a cotton swab. Migrated cells at the lower surface of the insert were visualized under an inverted bright field microscope and 5 to 8 random images were captured for each membrane. The numbers of migrated cells were then expressed as the average of total field per membrane in triplicate for each experimental condition.
Effect of rha-MIF on pancreatic tumor growth in vivo
Syrian golden hamsters (3-4 months old; male) were inoculated subcutaneously with and tumors were harvested. After measuring the tumor weights, the samples were preserved and processed for histopathological analysis.
Histology and immunohistochemistry
Hap-T1 tumors were dissected and fixed in 10% neutral buffered formalin at room temperature for 48 hours, and then tumor tissues were dehydrated and embedded in paraffin wax. 5 µm thick sections were cut and stained with hematoxylin-eosin. 
Results
Expression and purification of Syrian golden hamster recombinant MIF (rha-MIF)
Although MIF was the first described cytokine, its role in some important pathophysiological conditions across different species has still remained a grey area.
MIF from human and mouse or even from different human parasites have been structurally and functionally characterized [34] [35] [36] . In this study, we cloned and purified Syrian golden hamster (Mesocricetus auratus) MIF as described in materials and methods section. In one of our previous studies, we had cloned hamster MIF coding sequence (CDS) from m-RNA isolated from hamster pancreatic stellate cells [10] .
Mouse genome is known to harbor multiple MIF-related sequences; however, only the true Mif gene has an intron/exon structure and a 5' untranslated region [37] . Figure 1) . The expressed and purified rha-MIF showed an approximate molecular mass of about 12.5 kDa with more than 95% purity as observed from 18% SDS-PAGE, stained with Coomassie Brilliant Blue ( Figure 1A) . 
Crystal Structure of hamster rha-MIF
The rha-MIF crystal belonged to the orthorhombic P212121 space group with a = 53.88 Å, b = 55.85 Å, c = 112.16 Å, α=β=γ=90° as unit cell parameters. X-ray diffraction data collected at ESRF-ID30A-3 beamline was used to solve the structure. The data collection and refinement statistics are given in table 1. The crystal structure of rha-MIF was resolved to 1.8 Å resolution. It forms a trimer, with three identical molecules in an asymmetric unit. A monomer of rha-MIF is made up of six beta strands, four of which form a mixed beta sheet within one subunit, two antiparallel alpha helices and two shorter beta strands on either end of the sheet ( Figure 2C ). Also, a very small beta strand (β7) is present towards the C-terminus. The monomer structure is highly conserved among MIF from human, mouse and hamster, as could be observed from the structure alignment ( Figure 2C) . The RMSD for the Cα backbone atoms between hamster and human MIF (PDB id: 3djh) and between hamster and mouse MIF (PDB id: 1mfi) are 0.24 Å and 0.26 Å, respectively. The trimer adopts a barrel-like architecture formed by three inter-connected monomeric subunits (Figure 2D ), as has been reported for other MIF structures. The trimeric rha-MIF structure is retained by the short beta strands β3 of one monomer and β6 of the third monomer becoming part of the beta sheet formed by the beta strands β1, β2, β4 and β5 of the second monomer in between, together forming a six-stranded beta sheet. Herein, β3 of monomer-1 comes in close proximity and form hydrogen-bond network, typical of beta sheets, with β2 of the monomer-2 and β6 of monomer-3 comes close to β5 of monomer-2. This contribution of beta strands by all three monomers to their respective adjacent monomers to form beta sheets seems to provide stability to the trimeric structure. In the trimeric ring structure of MIF, the beta sheets of the three monomers together form a solvent-accessible central water channel, whose role in the context of MIF function is still not known [34] . A MIF trimer has been reported to have three catalytic pockets for tautomerase activity, located in the monomer-monomer interface between the three monomers ( Figure 2D) . The residues Pro2, Lys33 and Ile65 from one monomer and the residues Tyr96' and Asn98' from its adjacent monomer [38] , together form the catalytic pocket responsible for the tautomerase activity in human and mouse MIF and these residues are conserved in hamster MIF as well. This would explain why rha-MIF also shows tautomerase activity (described in the next section). Tautomerase activity of human MIF is known to be inhibited by the MIF-inhibitor ISO-1 [39] . ISO-1 binds to the residues Pro2, Lys33, Ile65 and Asn98' [40] , all of which form part of the tautomerase catalytic site located at the interface of two monomers ( Figure 
Tautomerase activity of rha-MIF
Unlike all other cytokines, MIF has a tautomerase activity, and it performs this enzymatic function through an N-terminal catalytic proline base [44] . In this study, the tautomerase activity of the purified rha-MIF was analyzed using L-dopachrome methyl ester substrate. The activity was determined after background correction for the nonenzymatic activity (dopachrome dependent non-specific activity; Supplementary Figure 3) . The rate of tautomerase activity of the protein (i.e., the amount of the product formed per second) showed a typical enzymatic response, wherein activity increased with increasing concentration of protein at lower concentrations and revealed a saturation tendency at higher concentrations ( Figure 3A) . The initial velocities of the reaction were measured as a function of substrate concentration from 0 to 800 μM (nmol ml -1 ). The data presented in Figure 3B was used to determine the Km by nonlinear least squares fit method following simple Michaelis-Menten equation ( Figure   3C ). The calculated Km value is 665 μM (nmol ml -1 ).
Effect of rha-MIF on activation and migration of PBMCs
MIF is known as a potent pro-inflammatory cytokine and regulates activation and migration of immune cells [45] . Exogenous MIF treatment induces expression of various pro-inflammatory cytokines (e.g. TNF-, IL-6, IL-1, and IL-8) and
angiogenic factors (e.g. VEGF) in different immune and/or endothelial cells [46] [47] [48] .
In this study, we investigated the effect of endotoxin-free rha-MIF on the activation of PBMCs [45] . Hence, we wanted to check whether ha-MIF has a similar effect on the migration properties of haPBMCs. The results of our trans-well migration assay showed significantly higher number of migrated PBMCs (p<0.0001) in conditions where rha-MIF was used as a chemoattractant than the control ( Figure 3E ).
Effect of rha-MIF on the growth of Hap-T1 pancreatic tumor in its syngeneic host
In pancreatic cancer patients, the tumor tissues and circulating blood have a higher level of MIF than in healthy subjects [49, 50] . However, in these approaches, the effect of MIF produced by normal cells on cancer cells (paracrine effects) is not being addressed. Hence, in the current study, we evaluated the impact of rha-MIF on the growth of HapT1 tumors in its syngeneic host.
The data in Figures 4A and 4B shows that systemic administration of rha-MIF significantly enhanced Hap-T1 tumor growth. Though tumor uptake was 100% in both PBS and rha-MIF injected groups, but after 20 days of cancer cells injection, the tumor weight of rha-MIF injected tumors was significantly higher (p<0.0005) than PBS injected tumors ( Figure 4C) . Moreover, the presence of a substantially higher number of Ki67-positive cells (p<0.0001) in the tumors of rha-MIF-injected animals than PBS injected animals ( Figures 4D and 4E) corroborates the observed pro-tumorigenic effect of exogenous MIF on pancreatic tumors in vivo.
Discussion
The cross-reactivity of MIF polyclonal antibody (NBP1-81832; Novus Biologicals) generated against a recombinant human MIF having 89% identity with Syrian hamster MIF indicates conserved antigenic epitopes in human and hamster MIF. Moreover, these results confirm the reliability of using NBP1-81832 antibody to detect Syrian golden hamster MIF. Primary sequence and crystal structure analysis of rha-MIF showed that mouse and hamster have almost similar level of identities with human MIF, which indicates that experiments related to MIF in mouse and hamster might have also similar outcomes. However, it will be apt to mention that the overall outcome of an experimental intervention in any animal model depends on multiple factors like the animal's genetic makeup, physiology, natural behavior, etc. Hence, in certain instances, hamster might be a more clinically relevant model than mice and vice versa. For example, hamster is a good host for multiple infectious agents to which mouse are resistant [52] . To investigate the role of MIF in the pathogenesis of these diseases, hamster model might be instrumental. Moreover, conserved structural features like the active site for tautomerase and ISO-1 binding in hamster MIF further justifies the suitability and relevance of this model in MIF-related studies (Figures 2D and 2E;   Supplementary Figure 2) . A study has shown that the diameter of the central channel of MIF from parasites like Giardia lamblia and Plasmodium species is narrower than that of human MIF. This structural difference between human-and parasite-MIF central channels might form a basis for structure-based drug design against the parasites [53] .
A wider channel size in human-and hamster-MIF ( Figure 2D) indicates that this structure might have a functional significance in vertebrates, which warrants further investigation.
The Km value of rha-MIF protein ( Figure 3C) is not in agreement with the MIF proteins of other species (2.4 mM: [54] ; 2.7 mM: [55] ; 2.1 mM: [56] ). This enzyme, was found to have much superior activity, with nearly 4-fold higher sensitivity towards L-dopachrome. This difference might be due to an itrinsic superior enzymatic activity of hamster MIF and/or difference associated with the technical process (protein quality, instrument sensitity, etc.). A further in-depth investigation to compare the tautomerase activity of hamster MIF and human MIF, using the same techical procedure might be helpful while exploring for effective MIF-inhibitors. Being a conserved protein and having a unique combination of hormone-, cytokine-and thioredoxin-like properties, MIF is considered as a potent cytokine with pleiotropic effects on immune and inflammatory events [57] . It is known to regulate expression of pro-inflammatory mediators leading to early patient death in sepsis [58, 59] . At the same time, human MIF is known to have differential effect on the migratory properties of various cell types [45] . The recruitment of immune cells to the site of infection leads to clearance of viral, bacterial and fungal infection but on the other hand, monocytes also contribute to their pathogenesis and inflammation [60] . Effect of hamster MIF in augmenting the directional migration of hamster PBMCs towards it shows its chemo-attractant property similar to human MIF ( Figure 3E ) [45] . Moreover, the effect of ISO-1 in inhibiting the rha-MIF mediated upregulation of the expression of proinflammatory molecules and migration of hamster PBMCs, corroborates the information obtained from the structural analysis of rha-MIF. These data further suggest that, ISO-1 could be reliably used as a ha-MIF inhibitor in various in vitro and in vivo studies.
Due to its remarkable involvement in cytokine cascade in tumor microenvironment, MIF is described as the connecting link bridging cancer with inflammation [61] and it is also known to be implicated in angiogenesis in multiple cancer types [62] [63] [64] . 
Conclusion
In the current study, hamster MIF has been cloned, expressed and purified for the first time, which will be of immense value for future studies. The crystal structure of MIF will provide direction to study binding affinity of drugs or inhibitors for therapeutic targeting, which will facilitate experiments on the functional role of MIF in different pathological conditions in a hamster model. As we show hamster MIF to be active both enzymatically and biologically, we believe this work will lead to improved strategies for understanding this molecule in the context of different diseases, including cancer in a hamster model. Importantly, the current study provides convincing experimental evidence which suggests that hamster model of pancreatic cancer can be reliably used to investigate MIF related questions in pancreatic cancer. Images were captured at 40× magnification.
(E) Graph showing number of Ki67 positive cells/field. Each bar represents the mean ± the SEM for five hamsters per group. ***p < 0.0001 using a Student t test.
